Haven: The strategy that didn’t fix healthcareJohn Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, Share XHaven: The strategy that didn’t fix healthcarehttps://pharmaphorum.com/views-analysis-market-access/haven-strategy-healthcare/
4 principles for the future of pharma marketingCOVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? Share X4 principles for the future of pharma marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/4-principles-future-pharma-marketing/
Why starting an innovation journey isn’t sexyChugai Pharmaceutical’s UK innovation lead, Martin Ellgood explores the challenges pharma companies face when devising innovation strategies. On Share XWhy starting an innovation journey isn’t sexyhttps://pharmaphorum.com/r-d/views-analysis-r-d/why-starting-an-innovation-journey-isnt-sexy/
Ireland is open: The biologics boom boosting the Irish economyThe life sciences industry has an important role in the Irish economy, with sectors such as biologics booming Share XIreland is open: The biologics boom boosting the Irish economyhttps://pharmaphorum.com/views-analysis-market-access/ireland-is-open-the-biologics-boom-boosting-the-irish-economy/
Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systemsInjected neurotoxins can be incredibly potent in treating spasticity from neurological diseases, but the field doesn’t always get Share XIpsen’s John Chaddock on making neurotoxins a priority for healthcare systemshttps://pharmaphorum.com/r-d/views-analysis-r-d/ipsens-john-chaddock-on-making-neurotoxins-a-priority-for-healthcare-systems/
Richard Francis on his Purespring plans: the pharmaphorum podcastIn this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took Share XRichard Francis on his Purespring plans: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/richard-francis-purespring-gene-therapy/
Health Innovators: Sergey Young on how technology can extend human lifeHow can humans extend their life span? In the second episode of our Health Innovators series, Paul Tunnah Share XHealth Innovators: Sergey Young on how technology can extend human lifehttps://pharmaphorum.com/digital/health-innovators-sergey-young-on-how-technology-can-extend-human-life/
Omnichannel customer-centric teams and the future of pharma CRMIf pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move Share XOmnichannel customer-centric teams and the future of pharma CRMhttps://pharmaphorum.com/views-and-analysis/omnichannel-customer-centric-teams-and-the-future-of-pharma-crm/
Increasing patient engagement with UK clinical trialsPharma companies face many challenges when involving patients in the design of clinical trials – but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/r-d/views-analysis-r-d/increasing-patient-engagement-with-uk-clinical-trials/
